Fl
Flagship Labs
Cambridge MAFounded 2000200 employees
Private CapbiotechPrivateOncology
Platform: Venture Create
Market Cap
N/A
All Drugs
3
Clinical Trials
5
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Olpaosocimab | FLA-2710 | NDA/BLA | 2 | CD47 | AMLPNH | ||
| FLA-9061 | FLA-9061 | NDA/BLA | 2 | JAK2 | SCDEwing Sarcoma | ||
| Tirazanubrutinib | FLA-2179 | Phase 1 | 1 | ALK | RACKD |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)